MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1212/wnl.0b013e3182918c2d

Медицинская библиотека · Neurology · 2013

Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease.

Storch Alexander, Wolz Martin, Beuthien-Baumann Bettina, Löhle Matthias, Herting Birgit, Schwanebeck Uta, Oehme Liane, van den Hoff Jörg, Perick Maria, Grählert Xina, Kotzerke Jörg, Reichmann Heinz

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To evaluate the effects of levodopa and the dopamine D2 agonist cabergoline on striatal dopamine turnover estimated as the inverse of the effective dopamine distribution volume ratio (EDVR) measured by (18)F-dopa PET in de novo Parkinson disease (PD).

METHODS

Single-center, parallel-group, randomized, observer-blinded study of cabergoline (3 mg/day) and levodopa (300 mg/day) over 12 weeks in patients with de novo PD. Primary efficacy measure was the change of the side-to-side averaged putaminal EDVR comparing baseline and end-of-maintenance period.

RESULTS

Thirty-five out of 39 randomized patients were assigned to the primary efficacy analysis (cabergoline, n = 17; levodopa, n = 18). At the end of treatment period, mean EDVRs were significantly lower compared to baseline solely in the levodopa group (relative change -1.0 ± 13.0% in cabergoline [p = 0.525 when compared to baseline], -8.3 ± 11.8% in levodopa group [p = 0.006]) with a nonsignificant trend between groups (mean relative difference: 7.3% (95% confidence interval -1.2% to 15.8%; p = 0.091). There was significant clinical improvement in both groups at 12 weeks compared to baseline, but no significant differences between groups in clinical and PET secondary outcome measures. Both pharmacologic treatments and PET scanning were well-tolerated and safe.

CONCLUSION

Putaminal dopamine turnover is increased by levodopa treatment in de novo PD. The nonsignificant trend toward a larger influence by levodopa compared to cabergoline is supported by ancillary statistical analyses. This augmentation of early compensatory events by levodopa might contribute not only to its symptomatic effects, but also to its induction of motor complications.

Для цитирования: Storch Alexander, Wolz Martin, Beuthien-Baumann Bettina, Löhle Matthias, Herting Birgit, Schwanebeck Uta, Oehme Liane, van den Hoff Jörg, Perick Maria, Grählert Xina, Kotzerke Jörg, Reichmann Heinz. Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease.. Neurology. 2013. DOI: 10.1212/wnl.0b013e3182918c2d.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.